Join NJ ACTS for a Special Lecture on 12/19, 12-1:30

Resources for Researchers through the CTSA Trial Innovation Network Daniel Ford, MD, MPH Director, Johns Hopkins Institute for Clinical and Translational Research and Dixie Thompson, BSN, RN Director of Research & Science Utah Clinical & Translational Science...
NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.

NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.

NJIT’s Kathleen McEnnis, assistant professor of chemical and materials engineering, is pioneering a new approach in cancer treatment through innovative drug-delivery nanoparticles. Her research focuses on treating aggressive types of breast cancer, using...